EMEA-002342-PIP02-18-M01

Table of contents

Key facts

Invented name
Verzenios
Active substance
abemaciclib
Therapeutic area
Oncology
Decision number
P/0439/2021
PIP number
EMEA-002342-PIP02-18-M01
Pharmaceutical form(s)
  • Film-coated tablet
  • Age-appropriate oral solid dosage form
Condition(s) / indication(s)
  • Treatment of glioma
  • Treatment of neuroblastoma
Route(s) of administration
Oral use
Contact for public enquiries
Eli Lilly and Company Limited (US)

Tel.: +1 31 75448941
E-mail: wagle_asvari@lilly.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

Related content

How useful was this page?

Add your rating